Explicit criteria for Potentially Inappropriate Medications in Older Adults: A comprehensive systematic review.

Context: Potentially inappropriate medications (PIMs) refer to the use of a medication whose risks outweigh the potential benefits in older adults, especially when other effective alternatives are available.</p><p>Aims: To identify and analyze explicit criteria developed for detecting PI...

Descripción completa

Detalles Bibliográficos
Autores: Alemán Fernández, Eliezer, Siverio Mota, Dany, Vicet Muro, Liliana, Braza Reyes, Antonio J., Viñas Bastart, Montserrat, Modamio Charles, Pilar, Delgado-Hernández, René
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/224776
Acceso en línea:https://hdl.handle.net/2445/224776
Access Level:acceso abierto
Palabra clave:Persones grans
Medicaments
Envelliment
Older people
Drugs
Aging
Descripción
Sumario:Context: Potentially inappropriate medications (PIMs) refer to the use of a medication whose risks outweigh the potential benefits in older adults, especially when other effective alternatives are available.</p><p>Aims: To identify and analyze explicit criteria developed for detecting PIMs in older adults, highlighting methodological approaches and pharmacological classifications.</p><p>Methods: A comprehensive literature search was conducted across seven databases from January 1990 to December 2024, following the PRISMA 2020 guidelines. Criteria developed using expert consensus or evidence-based processes were included.</p><p>Results: Out of 3,119 articles, 68 met the inclusion criteria. The Beers and STOPP/START tools were most frequently cited. The Delphi method was the predominant approach for validating the selected tools (73.53%). Commonly flagged medications included tricyclic antidepressants, NSAIDs, and benzodiazepines.</p><p>Conclusions: Numerous validated tools exist, although variations in validation methods and drug classification were observed. A global update and harmonization of explicit criteria are necessary for improved geriatric pharmacotherapy.</p><p>Keywords: Beers criteria; Delphi method; deprescribing tools; older adults; potentially inappropriate medications; STOPP START criteria.